发明名称 |
USE OF (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID IN COMBINATION |
摘要 |
PROBLEM TO BE SOLVED: To provide a method of treating hematologic disorders such as leukemia.SOLUTION: The treatment method comprises administering to a mammal having leukemia a therapeutically effective combination of an enantiomerically pure (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid and Ara-C (cytarabine), where the Ara-C is administered in a total amount of about 5-1500 mg/mper day for at least one day. |
申请公布号 |
JP2014040437(A) |
申请公布日期 |
2014.03.06 |
申请号 |
JP20130198807 |
申请日期 |
2013.09.25 |
申请人 |
SUNESIS PHARMACEUTICALS INC |
发明人 |
ADELMAN DANIEL C;SILVERMAN JEFFREY A;MICHELSON GLENN;SCATENA CAROLINE DARNE |
分类号 |
A61K31/7068;A61K31/282;A61K31/366;A61K31/395;A61K31/407;A61K31/4375;A61K31/513;A61K31/519;A61K31/704;A61K31/7048;A61K33/24;A61K38/00;A61K45/00;A61P35/02 |
主分类号 |
A61K31/7068 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|